Invitrogen™ eBioscience™ Normal Mouse Serum
Can be used to inhibit nonspecific binding of mouse monoclonal antibodies during staining for flow cytometric analysis. eBioscience™ Normal Mouse Serum can also be used in other applications which require normal mouse serum.
Manufacturer: Invitrogen™ 24554494
Can be used to inhibit nonspecific binding of mouse monoclonal antibodies during staining for flow cytometric analysis. It can also be used in other applications which require normal mouse serum.
Normal Sera are non-immune serum samples from goat, human, mouse, rabbit and other species that contain the usual complement of serum proteins, including the various classes of immunoglobulins that exist in healthy animals of the particular species. Normal serum provides a sufficient quantity of endogenous proteins to saturate and block nonspecific binding sites on fixed samples or assay substrates. When used as an antibody diluent, non-immune serum also supplies a native chemical environment for antibodies to function properly without adding foreign protein components. Normal serum is frequently used for blocking or saturating generalized binding interactions for immunodetection methods, especially those involving tissue samples such as immunohistochemistry (IHC). Normal sera are also useful as controls for testing general and specific antibody purification methods.
2° to 8°C. For extended storage (>3 months), aliquot and freeze the product at −20°C or below.
|Intracellular Staining Followed by Flow Cytometric Analysis|
|Contains 0.09% sodium azide|
|2° to 8°C. For extended storage (>3 months), aliquot and freeze the product at −20°C or below.|
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok